User menu

The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.

Bibliographic reference Evans, Christopher P ; Higano, Celestia S ; Keane, Thomas ; Andriole, Gerald ; Saad, Fred ; et. al. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.. In: European Urology, Vol. 70, no.4, p. 675-683 (2016)
Permanent URL http://hdl.handle.net/2078.1/178992